Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence DAHKSEVAHRFKD
Primary information
sequence IDSeq_1090
Peptide sequenceDAHKSEVAHRFKD
CancerPDF_ID CancerPDF_ID8607, CancerPDF_ID10184, CancerPDF_ID11342,
PMID23667664,21805675,26992070
Protein NameSerum albumin,Serum albumin precursor,Serum albumin
UniprotKB Entry NameALBU_HUMAN,ALBU_HUMAN,ALBU_HUMAN
FluidSerum,Urine,Serum
M/Z1538.76,1539.7496,1538.759
Charge1,NA,NA
Mass (in Da)1540.68,NA,1539.769016
fdrNA,NA,NA
Profiling TechniqueMALDI-TOF,MALDI-TOF,LC-MS
Peptide Identification techniqueFT-ICR MS/MS + nano-HPLC,MALDI-TOF-MS,LC-MS/MS
Quantification TechniqueNA,NA,NA
Labelled/Label FreeLabel Free,Label Free,Label Free
FDRNA,1,FDR 1 %
CancerPDF_ID CancerPDF_ID8607, CancerPDF_ID10184, CancerPDF_ID11342,
p-ValueNA,NA,NA
SoftwareMASCOT,NA,SEQUEST and Maxquant
Length13,13,13
Cancer Type"Breast cancer, Lung cancer, Rectal cancer",Muscle-invasive bladder cancer,Melanoma
DatabaseNA,SwissProt Database,SwissProt Database
ModificationNA,NA,NA
Number of Patients"Breast Cancer =84, lung cancer= 70, Rectal cancer = 30patients; 500 healthy",751 bladder cancer and 127 control,8 cancer samples and 4 healthy samples
RegulationNA,Differentially expressed between cancer vs normal samples,"Present in 8 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples."
ValidationNA,Mann-Whitney tests and areas under receiver-operator characteristic,na
SensitivityNA,NA,NA
SpecificityNA,NA,NA
AccuracyNA,NA,NA
Peptide AtlasPeptideAtlas
IEDB436751